Shares of DocuSign, Inc. (NASDAQ:DOCU – Get Free Report) have been given an average recommendation of “Hold” by the thirteen research firms that are presently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell recommendation, seven have assigned a hold recommendation and three have issued a buy recommendation on the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $92.45.
Several research firms have commented on DOCU. HSBC restated a “reduce” rating on shares of DocuSign in a research note on Friday, December 6th. UBS Group lifted their target price on DocuSign from $60.00 to $100.00 and gave the company a “neutral” rating in a research report on Friday, December 6th. Royal Bank of Canada restated a “sector perform” rating and issued a $90.00 price target (up from $57.00) on shares of DocuSign in a research note on Friday, December 6th. Needham & Company LLC reissued a “hold” rating on shares of DocuSign in a report on Tuesday, February 4th. Finally, Piper Sandler upped their price target on shares of DocuSign from $60.00 to $90.00 and gave the stock a “neutral” rating in a research report on Friday, December 6th.
Check Out Our Latest Research Report on DocuSign
Insider Buying and Selling at DocuSign
Institutional Trading of DocuSign
A number of institutional investors have recently added to or reduced their stakes in the stock. Toronto Dominion Bank grew its position in DocuSign by 30.3% in the third quarter. Toronto Dominion Bank now owns 26,159 shares of the company’s stock worth $1,624,000 after acquiring an additional 6,081 shares in the last quarter. Inspire Investing LLC bought a new position in shares of DocuSign in the 3rd quarter worth approximately $911,000. Charles Schwab Investment Management Inc. lifted its position in DocuSign by 1.2% during the third quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock valued at $82,478,000 after buying an additional 16,014 shares during the period. International Assets Investment Management LLC lifted its position in DocuSign by 5,660.8% during the 3rd quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock valued at $27,252,000 after acquiring an additional 431,295 shares during the period. Finally, Quantinno Capital Management LP boosted its position in shares of DocuSign by 39.5% in the 3rd quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock worth $12,514,000 after purchasing an additional 57,104 shares in the last quarter. Hedge funds and other institutional investors own 77.64% of the company’s stock.
DocuSign Trading Up 0.4 %
DOCU stock opened at $90.86 on Tuesday. The firm has a market cap of $18.36 billion, a PE ratio of 18.73, a P/E/G ratio of 7.56 and a beta of 0.89. The business’s 50-day moving average price is $92.58 and its two-hundred day moving average price is $74.47. DocuSign has a 1-year low of $48.70 and a 1-year high of $107.86.
DocuSign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
- Five stocks we like better than DocuSign
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Growth Stocks: What They Are, What They Are Not
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- What is Put Option Volume?
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.